See also this year's filing and all EDGAR filings for this company.
PDF Report 0001062822_2023_LEXICON_PHARMACEUTICALS_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.6988040285354595, 'aggregate_val': 77175000, 'exp_sum': 28596000, 'exp_to_value': {'LiabilitiesCurrent': 23172000, 'LiabilitiesNoncurrent': 5424000, 'remainder_Liabilities': 0}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001062822, LEXICON PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 140,866,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 44,543,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,071,000 |
| 3 | remainder_Assets | 6,819,000 |
| 4 | LiabilitiesCurrent | 23,172,000 |
| 5 | LiabilitiesNoncurrent | 5,424,000 |
| 6 | remainder_Liabilities | 48,579,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 48,083,000 |
| 9 | ResearchAndDevelopmentExpense | 52,816,000 |
| 10 | remainder_Expenses | 2,780,000 |
| 11 | remainder_Revenues | 139,000 |
| 12 | remainder_NetIncome | 1,596,000 |
| 13 | remainder_ComprehensiveNetIncome | -418,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 194,299,000 |
| 1 | Liabilities | 77,175,000 |
| 2 | Expenses | 103,679,000 |
| 3 | Revenues | 139,000 |
| 4 | StockholdersEquity | 117,124,000 |
| 5 | NetIncome | -101,944,000 |
| 6 | ComprehensiveNetIncome | -102,153,000 |
| 7 | BaseVar | 188,653,000 |
| 8 | EconomicCapitalRatio | 0.732 |
Edgar->Model Mapping
Feature Distribution
Change over Time
